The effect of lipid composition and physical state of phospholipid monolayer on the binding and incorporation of a basic amphipathic peptide from the C-terminal region of the HIV envelope protein gp41

Chemistry and Physics of Lipids

Volumn 107, Issue 1, 2000, Pages 83-92

  Trommeshauser, Dirk ^a   Krol, Silke ^a   Bergelson, Lev D ^b   Galla, Hans Joachim ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Electrostatic interaction; Film balance; HIV envelope glycoprotein; Lipid monolayer; Lipid peptide interaction

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; GLYCOPROTEIN GP 41; PEPTIDE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLSERINE; PHOSPHOLIPID;

ALPHA HELIX; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CLUSTER ANALYSIS; HYDROPHOBICITY; LIPID COMPOSITION; MONOLAYER CULTURE; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; VIRUS ENVELOPE;

AMINO ACID SEQUENCE; CALCIUM; HIV ENVELOPE PROTEIN GP41; LIPID BILAYERS; LIPID METABOLISM; LIPIDS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHOSPHOLIPIDS; PROTEIN BINDING;

EID: 0034284473     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-3084(00)00153-5     Document Type: Article

References (34)

1. Bechinger B. Topologies of α-helical peptides in lipid bilayers by solid-state NMR spectroscopy. Eur. Biophys. J. 26:1997;65.
2. Bringezu F., Brezesinski G., Nuhn P., Möhwald H. Chiral discrimination in a monolayer of a triple-chain phosphatidylcholine. Biophys. J. 70:(4):1996;1789-1795.
3. j (i=2j) peptides to acquire optimal hemolytic activity. Biochim. Biophys. Acta. 1416:1999;161-175.
4. Chernomordik L., Chanturiya A., Suss-Toby E., Nora E., Zimmerberg J. An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J. Virol. 68:1994;7113-7123.
5. Degrado W.F., Kezdy F.J., Kaiser E.T. Design, synthesis and characterization of a cytotoxic peptide with melittin like activity. J. Am. Chem. Soc. 103:1981;679-681.
6. Eisenberg D., Wesson H. The most highly amphiphilic a-helices include two amino acid segments in human immunodeficiency virus glycoprotein 41. Biopolymers. 29:1990;171-177.
7. Epand R.M., Gawrisch A., Iqbal M., Gupta K.B., Chen C.H., Segrest J.P., Anantharamaiah G.M. Studies of synthetic peptide analogs of the amphipathic helix: effect of charge distribution, hydrophobicity and secondary structure on lipid association and lecithin:cholesterol acyltransferase activation. J. Biol. Chem. 262:1987;9389-9396.
8. Epand R.M., Surewicz W.K., Hughes D.W., Mantsch H., Segrest J.P., Allen T.M., Anantharamaiah G.M. Properties of lipid complexes with amphipathic helix forming peptides. Role of distribution of peptide charges. J. Biol. Chem. 264:1989;4628-4635.
9. Epand R.M., Shai Y., Segrest L.P., Anantharamaiah G.M. Mechanisms for the modulation of membrane bilayer properties by amphipathic helical peptides. Biopolymer. 37:1995;319-338.
10. Gawrisch K., Barry J., Holte L., Sinnwell T., Bergelson L., Ferretti J. Role of interactions at the lipid-water interface for domain formation. Mol. Membr. Biol. 12:1995;83-88.
11. Gawrisch K., Han K., Yang L., Bergelson L., Ferretti J. Interaction of peptide fragment 828-848 of the envelope glycoprotein of human immunodeficiency virus type I with lipid bilayers. Biochemistry. 32:1992;3112-3118.
12. Grant E., Beeler T.L., Taylor K.M.P., Gable K., Roseman M.A. Mechanism of magainin 2a induced permeabilization of phospholipid vesicles. Biochemistry. 31:1992;9912-9918.
13. Haffar O., Dowbenko D., Berman P. Topogenic analysis of the human immunodeficiency virus type 1 envelope glycoprotein, gp160, in microsomal membranes. J. Cell Biol. 107:1988;1677-1687.
14. Haffar O., Dowbenko D., Berman P. The cytoplasmic tail of HIV-I gp160 contains regions that associate with cellular membranes. Virology. 180:1991;439-441.
15. Kaiser E.T., Kezdy F.J. Surface properties of an amphiphilic peptide hormone and its analog: corticotropin-releasing factor and sauvagine. Proc. Natl. Acad. Sci. USA. 80:1983;1137-1143.
16. Kaiser E.T., Kezdy F.J. Amphiphilic secondary structure: design of peptide hormones. Science. 223:1984;249-255.
17. Koenig B., Bergelson L., Gawrisch K., Ward J., Ferretti J. Effect of the conformation of a peptide from gp41 on binding and domain formation in model membranes. Mol. Membr. Biol. 12:1995;77-82.
18. Lee S., Hu W., Fischer A.G., Looney D.L., Kao W.R., Mitsuya H., Ratner L., Wong-Staal F. Role of the carboxy-terminal portion of the HIV-1 transmembrane protein in viral transmission and cytopathogenity. AIDS Res. Hum. Retroviruses. 5:1989;441-449.
19. Martin L., Ruysschart L.-M. Comparison of lipid vesicle fusion induced by the putative fusion peptide of fertilin (a protein active in spenn-egg fusion) and the NH2-terminal domain of the HIV-2 gp41. FEBS Lett. 405:(3):1997;351-355.
20. Matzusaki K., Harada M., Handa T., Funakoshi S., Fujii N., Yajima H., Miyajima K. Magainin 1 induced leakage of entrapped calcein out of negatively charged lipid vesicles. Biochim. Biophys. Acta. 981:1989;130-134.
21. Meyer K.L., Marasco C.J. Jr, Morris-Natschke S.L., Ishaq K.S., Piantadosi C. In vitro evaluation of phosphocholine and quaternary ammonium containing lipids as novel anti-HIV agents. J. Med. Chem. 34:1991;1377-1383.
22. Miller M., Montelaro R.C. Aloia R.C., Curtain C.C. Membrane Interactions of HIV. 1992;351-364 Wiley Liss, New York.
23. Moe G.R., Kaiser E.T. Design, synthesis and characterization of a model peptide having calcitonin-like biological activity: implications for calcitonin structure/activity. Biochemistry. 24:1985;1971-1976.
24. Montal M., Mueller P. Formation of bimolecular membranes from lipid monolayers and a study of their electrical properties. Proc. Natl. Acad. Sci. USA. 69:1972;3561-3566.
25. Rafalski M., Lear J.D., DeGrado W.F. Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41. Biochemistry. 29:1990;7912-7922.
26. Sarin P.S., Gallo R.C., Sheer D.J., Crews F., Lippa A.S. Effects of a novel compound (AL 72 1) on HTLV-III infectivity in vitro. N. Engl. J. Med. 313:1985;1289-1290.
27. Schwarz G., Taylor S.E. Thermodynamic analysis of the surface activity exhibited by a largely hydrophobic peptide. Langmuir. 11:1995;4341-4346.
28. Segrest J.R., DeLoof H., Dohlman J.G., Brouilette C.G., Anantharamaiah G.M. Amphipathic helix motif: classes and properties. Proteins. 8:1990;103-117.
29. Srinivas S., Srinivas R., Anantharamaiah G.M., Segrest J., Compans R. Membrane interactions of synthetic peptides corresponding to aniphipathic helical segments of the HIV type-1. J. Biol. Chem. 267:1992;7121-7127.
30. Stanislawski B., Rueterjans H. 13 C NMR investigation of the insertion of the bee venom melittin into lecithin vesicles. Eur. Biophys. J. 15:1987;1-12.
31. Terwilliger T.C., Weissmann L., Eisenberg D. The structure of melittin in the form I crystals and its implication for melittin's lytic and surface activities. Biophys. J. 37:1982;353-361.
32. Terzi E., HoIzemann G., Seelig J. Interaction of Alzheimer beta amyloid peptide (1-40) with lipid membranes. Biochemistry. 36:(48):1997;14845-14852.
33. Trommeshauser D., Galla H.A. Interaction of a basic amphipathic peptide from the carboxy terminal part of the HIV envelope protein gp41 with negatively charged lipid surfaces. Chem. Phys. Lipids. 94:1998;81-96.
34. Venable R., Pastor R., Brooks B., Carson F. Theoretically determined threedimensional structures for amphipathic segments of the HIV-1 gp41 envelope protein. AIDS Res. Human Retroviruses. 5:1989;7-22.